OVERVIEW

A New Age of DMD Management: Promoting Effective Transitions From Pediatric to Adult DMD Care is organized by Prime Education, LLC.

Release Date: March 13, 2023
Expiration Date: March 12, 2024

Description:
Disease-modifying treatments for Duchenne muscular dystrophy (DMD), a rare, progressive neuromuscular disease, have drastically evolved in recent years and greatly improved patient outcomes and quality of life. However, challenges in diagnosis and management persist. One key barrier is lack of effective transitions for individuals who are transitioning from pediatric to adult DMD care. For adolescents with DMD, this transition period is a critical time during which many experience severe organ dysfunction, lose ambulation, and require specialized multidisciplinary care.
In this 45-minute video activity, two renowned DMD experts discuss diagnostic strategies and evidence-based treatment and management of patients throughout the DMD care continuum, including best practices for effective pediatric to adult care transitions.
This activity is delivered in partnership with the Muscular Dystrophy Association and Parent Project Muscular Dystrophy.

Agenda:
• Overview of DMD Etiology, Pathophysiology, and Clinical Manifestations
• Case-Based Discussions: Evidence-Based Treatment and Management of Patients Throughout the DMD Care Continuum
• Patient- and Caregiver-Centered Care and Considerations for Treatment Decisions
• Barriers to and the Need for Effective Pediatric to Adult Transitions of Care for Patients With DMD
• Case-Based Discussions: Interprofessional Strategies for Optimizing Transitions From Pediatric to Adult DMD Care

Learning Objectives:
• Describe current guidelines and evidence for the diagnosis, treatment, and management of patients throughout the DMD care continuum
• Identify critical gaps in the care of patients as they transition from pediatric to adult DMD care and move between healthcare settings and providers
• Apply evidence-based and expert consensus strategies to support communication and care coordination among specialists involved in the diagnosis and co-management of DMD patients
• Develop comprehensive interprofessional care plans that account for individual patient's clinical needs, comorbidities, psychosocial concerns, and treatment goals and preferences.

Credits

 Joint Accreditation Statement
IPCE Credit™In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Interprofessional Teams
Joint AccreditationThis activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Physician Credit Designation Statement
PRIME® designates this Enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

 

Physician Assistant Accreditation Statement
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

 

Nurse Practitioner Accreditation Statement
Nurse Practitioner LogoPRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 0.75 contact hour (which includes 0.18 hour of pharmacology).

 

Pharmacist Accreditation Statement
This Knowledge-based activity has been approved for 0.75 contact hour (0.075 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-23-062-H01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service (help@nabp.pharmacy).

 

Nurse Accreditation Statement
PRIME® designates this activity for 0.75 contact hour.

 

Case Manager Accreditation Statement
The Commission for Case Manager Certification designates this educational activity for 0.75 contact hour for certified case managers. Credits for this program are pre-approved.

  • 0.75 CME/CE
  • 0.75 CNE
  • 0.75 CPE
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Contact Hours
  • 0.75 IPCE
  • 0.075 CEUs
  • 0.75 CE
  • TARGET AUDIENCE

    PhysicianCase ManagersNeurologistsPediatriciansMedical Geneticists

    SPECIALITIES

    PediatricsNeurologyGenetics

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    7.5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$149

    Webcast

    Emergency Medicine
    22 AMA PRA Category 1 Credits™
    ...
    More actions
    US$199
    33 AMA PRA Category 1 Credits™
    ...
    More actions
    US$499